From: High rate of bleeding and arterial thrombosis in COVID-19: Saudi multicenter study
 | Overall n = 636 | Non-ICU n = 530 | ICU n = 106 | p-value |
---|---|---|---|---|
Age (mean ± SD) | 49 ± 16 | 47 ± 16 | 59 ± 14 | < 0.0001 |
Male n (%) | 456 (71.7) | 371 (70) | 85 (80.2) | 0.033 |
Female n (%) | 180 (28.3) | 159 (30) | 21 (19.8) | Â |
Weight (mean ± SD) | 78.1 ± 16.2 | 77.2 ± 15.1 | 82.8 ± 20.3 | 0.007 |
BMI (mean ± SD) | 28.4 ± 6.0 | 28.1 ± 5.5 | 17.3 ± 7.8 | 0.075 |
a Any comorbidities n (%) | 303(47) | 205(38) | 98(92) | < 0.0001 |
bActive Cancer n (%) | 12 (1.9) | 9 (1.7) | 3 (2.8) | 0.432 |
History of Thrombophilia n (%) | 3 (0.47) | 1 (0.19) | 2 (1.8) | 0.073 |
History of DVT/PE n (%) | 6 (0.94) | 5 (0.95) | 1 (0.94) | 1.00 |